← Open Payments lookup

GRANT FABRY: Open Payments

NPI 1306527148 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,141 in 148 payments from 22 companies in 2025. Trend: 2023 $59 · 2024 $1,448 · 2025 $2,141

Food & beverage: $2,141
CompanyPaymentsAmount
ANI Pharmaceuticals, Inc.40$269
Calliditas Therapeutics US Inc.7$206
Boehringer Ingelheim Pharmaceuticals, Inc.15$204
Bayer Healthcare Pharmaceuticals Inc.11$187
Travere Therapeutics, Inc.10$179
Amgen Inc.12$155
Vifor Pharma, Inc.11$150
Otsuka America Pharmaceutical, Inc.8$148
Novartis Pharmaceuticals Corporation8$129
SCPHARMACEUTICALS INC.5$82

Products named: PURIFIED CORTROPHIN GEL, TARPEYO, JARDIANCE, Kerendia, TAVNEOS, Veltassa, JYNARQUE, Fabhalta.

Industry payments across NE — which companies pay providers there.